Testimonial Caitlin Perry IIIF Consortium
The IIIF Annual Conference 2026 welcomed around 230 participants from 20 countries to Leiden. We had considered several cities in the Netherlands, but Leiden really stood out to us.
1 to 6 of 156 results
Potential treatment for hereditary haemorrhagic telangiectasia
LUMC spin-off RougeTx has secured €50 million to advance RTX-001, a potential treatment for hereditary haemorrhagic telangiectasia (HHT). The drug candidate aims to stabilise blood vessels and progress towards clinical trials.
‘Mini earpieces’ provide new insights into hearing loss
Researchers at the LUMC are creating increasingly sophisticated ‘mini inner ears’ from stem cells. This enables them to investigate the causes of hearing loss more effectively and, in turn, to test new treatments.
Research explains the role of hormones in menstrual migraines
Researchers at the LUMC and Erasmus MC have discovered that women with menstrual migraine have a different oestrogen profile. This finding helps to explain why migraines occur just before menstruation and offers avenues for treatment.
New insights into the immune response in chronic bowel disease
Researchers at the LUMC have discovered immune cells that can both exacerbate and suppress inflammation in chronic bowel conditions. This dual role offers new insights into diseases such as Crohn’s disease and ulcerative colitis.
European project uses computational modelling to unlock how skin cancer spreads
How do melanoma cells spread through the body? Researchers at Leiden University are using advanced computer models to uncover the mechanisms behind skin cancer metastasis and identify new opportunities for prevention and treatment.